Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, $.0001 par value
-
Shares outstanding
-
10,619,449
-
Total 13F shares
-
517,050
-
Share change
-
+455,875
-
Total reported value
-
$5,428,886
-
Price per share
-
$10.50
-
Number of holders
-
21
-
Value change
-
+$5,381,384
-
Number of buys
-
21
-
Number of sells
-
1
Institutional Holders of Hepion Pharmaceuticals, Inc. - Common Stock, $.0001 par value (HEPA) as of Q2 2023
As of 30 Jun 2023,
Hepion Pharmaceuticals, Inc. - Common Stock, $.0001 par value (HEPA) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
517,050 shares.
The largest 10 holders included
VANGUARD GROUP INC, Octagon Capital Advisors LP, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, STATE STREET CORP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, RENAISSANCE TECHNOLOGIES LLC, PNC Financial Services Group, Inc., and UBS Group AG.
This page lists
21
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.